Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/30360
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Arslan, Muhammet | - |
dc.contributor.author | Değirmencioğlu, Serkan | - |
dc.date.accessioned | 2020-06-08T12:12:44Z | |
dc.date.available | 2020-06-08T12:12:44Z | |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1573-4056 | - |
dc.identifier.uri | https://hdl.handle.net/11499/30360 | - |
dc.identifier.uri | https://doi.org/10.2174/1573405615666181122145330 | - |
dc.description.abstract | Background: Transarterial Chemoembolization (TACE) is a minimally invasive treatment in managing unresectable liver primary neoplasms or liver metastases. Postembolization Syndrome (PES) is the most common adverse effect after TACE procedures. Objective: We investigate the risk factors for the development of PES after TACE therapy in patients with primary or metastatic liver tumors. Methods: In a retrospective analysis of 163 patients who underwent TACE between 01/01/2012 and 31/01/2018, patients that were given medication due to pain, fever, nausea or vomiting were evaluated and noted with PES. Analyses were made to evaluate factors such as age, gender, chemotherapy agent and dose, tumor size, tumor type, a particle used for embolization, multiple tumor treatments and selective application of the procedure, which may lead to PES after TACE. Results: In a total of 316 patients, PES was observed at a rate of 55 percent after TACE. Tumor size, number of tumors treated and adopting super selective fashion in the procedure were found to be related to the development of PES. No relationship was found between age, gender, presence of ascites, tumor type, size of embolic agent and drug type and the development of PES. Conclusion: A treated tumor measuring >5 cm, treating more than one tumor, and the failure to perform the procedure in a super selective fashion increase the risk of PES development after TACE. © 2019 Bentham Science Publishers. | en_US |
dc.language.iso | en | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cancer | en_US |
dc.subject | Complication | en_US |
dc.subject | Liver | en_US |
dc.subject | Postembolization syndrome | en_US |
dc.subject | Transcatheter arterial chemoembolization | en_US |
dc.subject | Tumor | en_US |
dc.subject | adult | en_US |
dc.subject | arterial embolization | en_US |
dc.subject | Article | en_US |
dc.subject | chemoembolization | en_US |
dc.subject | computer assisted tomography | en_US |
dc.subject | female | en_US |
dc.subject | fever | en_US |
dc.subject | human | en_US |
dc.subject | liver cell carcinoma | en_US |
dc.subject | loss of appetite | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | nausea and vomiting | en_US |
dc.subject | pain | en_US |
dc.subject | postembolization syndrome | en_US |
dc.subject | priority journal | en_US |
dc.subject | quality of life | en_US |
dc.subject | retrospective study | en_US |
dc.subject | risk factor | en_US |
dc.subject | tumor volume | en_US |
dc.subject | vascular access | en_US |
dc.title | Risk factors for postembolization syndrome after transcatheter arterial chemoembolization | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 15 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 380 | |
dc.identifier.startpage | 380 | en_US |
dc.identifier.endpage | 385 | en_US |
dc.authorid | 0000-0001-5565-0770 | - |
dc.authorid | 0000-0002-1213-2778 | - |
dc.identifier.doi | 10.2174/1573405615666181122145330 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 31989907 | en_US |
dc.identifier.scopus | 2-s2.0-85065965898 | en_US |
dc.identifier.wos | WOS:000464162000005 | en_US |
dc.identifier.scopusquality | Q3 | - |
dc.owner | Pamukkale University | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
19
checked on Aug 17, 2024
WEB OF SCIENCETM
Citations
18
checked on Aug 9, 2024
Page view(s)
78
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.